Your search for bevacizumab returned 6 results

Pembrolizumab plus chemotherapy with or without bevacizumab could be a new standard of care for first-line therapy in metastatic cervical cancer.

There was no improvement in overall survival with bevacizumab.

High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.

The approval was based on data from the phase 3 KEYNOTE-826 trial.

The checkpoint inhibitor cemiplimab improved survival in patients with recurrent/metastatic cervical carcinoma compared with single-agent chemotherapy.

Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.